Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
IDEAYA Biosciences’ $92 Million Common Stock Offering
ImmunityBio’s $500 Million At-the-Market Offering
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
ImmunityBio’s $500 Million At-the-Market Offering
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....